Dr Reddy’s Advocates for Policymaker-Industry Collaboration in Healthcare

Dr Reddy’s Advocates for Policymaker-Industry Collaboration in Healthcare

Dr Reddy’s Laboratories, a prominent Hyderabad-based pharmaceutical company, emphasizes the necessity of collaboration between policymakers and the industry to enhance healthcare delivery in India. The firm actively participated in the sixth Pre-Budget Consultation that Union Finance Minister Nirmala Sitharaman presided over. In this session, they shared their perspectives, including on how to fund innovation that takes risks. This initiative seeks to advance India’s pharma ecosystem, including speeding breakthroughs that deliver better patient access and affordability.

Satish Reddy, the chairman of Dr Reddy’s Laboratories, underscored the value of these partnerships. He provided this perspective in his recent roundtable consultation with industry leaders. He asserted that effective collaboration could pave the way for a healthcare system that serves millions of people across the nation. Dr. Reddy’s Laboratories is one of the largest players on the Indian pharmaceutical landscape. The company continually advances a culture that creates innovation and long-term, sustainable expansion.

Through the roundtable, Dr. Reddy’s Laboratories presented some of their key learnings on developing risk-based funding. They laid out their vision of how this model could re-energize therapy and drug innovation. The company lobbies vigorously to ensure the regulatory framework is welcoming. This strategy aims to shorten approval times and broaden market access for critical therapeutics.

“At Dr Reddy’s, we believe that partnerships between policymakers and industry are vital to building a future-ready healthcare system that serves millions.” – Satish Reddy

Dr Reddy’s mission is to provide access to affordable medicines through creative solutions. In the meantime, the company continues unabated with its harmful charter. It continually interacts with stakeholders on social media channels, particularly on LinkedIn, to raise awareness of its positive impacts on the healthcare ecosystem.

This consultation was an amazing opportunity for Dr. Reddy’s Laboratories to present their ideas directly to government officials. It provided a great chance to connect with other industry luminaries. By encouraging conversations around the most important issues, the corporation hopes to change policies that will improve the quality and availability of care.

Tags